Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment.

Volume 4 (2007), Issue 4 (April)

1. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
   J Infect Dis, 195(9): 1324-31. [Abstract] [Full-text]
2. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection.
   J Infect Dis, 195(9): 1270-7. [Abstract] [Full-text]
3. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania.
   J Infect Dis, 195(9): 1260-9. [Abstract] [Full-text]
4. Quantitative detection of herpes simplex virus DNA in the lower respiratory tract.
   J Med Virol, 79(5): 597-604. [Abstract] [Full-text]
5. Characterization of soluble glycoprotein D-mediated herpes simplex virus type 1 infection.
   Virology, 360(2): 477-91. [Abstract] [Full-text]
6. Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L.
   Virology, 360(2): 322-8. [Abstract] [Full-text]
7. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction.
   Virology, 360(2): 305-21. [Abstract] [Full-text]
8. In vivo fitness and virulence of a drug-resistant herpes simplex virus 1 mutant.
   J Gen Virol, 88: 1410-4. [Abstract] [Full-text]
9. Knockdown of DNA ligase IV/XRCC4 by RNA interference inhibits herpes simplex virus type I DNA replication.
   J Biol Chem, 282(15): 10865-72. [Abstract] [Full-text]
10. Differential responses of murine vaginal and uterine epithelial cells prior to and following herpes simplex virus type 2 (HSV-2) infection.
    Am J Reprod Immunol, 57(5): 367-77. [Abstract] [Full-text]
11. Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system.
    Biochim Biophys Acta, 1768(5): 1093-102. [Abstract] [Full-text]
12. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.
    Am J Respir Crit Care Med, 175(9): 935-42. [Abstract] [Full-text]
13. Herpes simplex virus type 1 tegument proteins VP1/2 and UL37 are associated with intranuclear capsids.
    Virology, 361(2): 316-24. [Abstract] [Full-text]
14. Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.
    Virology, 361(2): 372-83. [Abstract] [Full-text]
15. Visualization of the herpes simplex virus portal in situ by cryo-electron tomography.
    Virology, 361(2): 426-34. [Abstract] [Full-text]
16. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
    Antiviral Res, 75(1): 30-5. [Abstract] [Full-text]
17. Role of tumor invasiveness, the extracellular matrix, and chromatin sequestration in the susceptibility of uveal melanoma to herpes simplex virus type 1.
    Exp Eye Res, 84(5): 991-1000. [Abstract] [Full-text]
18. Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain.
    Antimicrob Agents Chemother, 51(5): 1596-607. [Abstract] [Full-text]
19. Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.
    Exp Eye Res, 84(5): 801-11. [Abstract] [Full-text]
20. Modulation of CD8+ CTL effector function by fibroblasts derived from the immunoprivileged cornea.
    Invest Ophthalmol Vis Sci, 48(5): 2194-202. [Abstract] [Full-text]
21. Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.
    Invest Ophthalmol Vis Sci, 48(5): 2185-93. [Abstract] [Full-text]
22. N-terminal mutants of herpes simplex virus type 2 gH are transported without gL but require gL for function.
    J Virol, 81(10): 5102-11. [Abstract] [Full-text]
23. Herpes simplex virus immediate-early protein ICP22 triggers loss of serine 2-phosphorylated RNA polymerase II.
    J Virol, 81(10): 5091-101. [Abstract] [Full-text]
24. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome.
    J Virol, 81(10): 5192-201. [Abstract] [Full-text]
25. Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient.
    Transpl Infect Dis, 9(2): 126-31. [Abstract] [Full-text]
26. Thrombin enhances herpes simplex virus infection of cells involving protease-activated receptor 1.
    J Thromb Haemost, 5(5): 1055-61. [Abstract] [Full-text]

© 2004-2008 Herpes Research Today. All Rights Reserved.